‘Remdesivir’
By AFP
October 17, 2020
Geneva: The antiviral drug remdesivir, considered one of the most promising Covid-19 treatments, turns out to do little to prevent deaths from the disease, according to a WHO-backed study.
Remdesivir, which was part of the experimental cocktail given to US President Donald Trump when he caught the new coronavirus last month, was one of several reviewed in a large study of more than 11,000 people across 30 countries.
-
Cuba-Canada Travel Advisory Raises Concerns As Visitor Numbers Decline -
Anthropic Buys 'Super Bowl' Ads To Slam OpenAI’s ChatGPT Ad Strategy -
Prevent Cancer With These Simple Lifestyle Changes -
Air Canada Flight Diverted St John's With 368 Passengers After Onboard Incident -
Experts Reveal Keto Diet As Key To Treating Depression -
Inter Miami Vs Barcelona SC Recap As Messi Shines With Goal And Assist -
David Beckham Pays Tribute To Estranged Son Brooklyn Amid Ongoing Family Rift -
Jailton Almeida Speaks Out After UFC Controversy And Short Notice Fight Booking -
Extreme Cold Warning Issued As Blizzard Hits Southern Ontario Including Toronto -
Lana Del Rey Announces New Single Co-written With Husband Jeremy Dufrene -
Ukraine-Russia Talks Heat Up As Zelenskyy Warns Of US Pressure Before Elections -
Lil Nas X Spotted Buying Used Refrigerator After Backlash Over Nude Public Meltdown -
Caleb McLaughlin Shares His Resume For This Major Role -
King Charles Carries With ‘dignity’ As Andrew Lets Down -
Brooklyn Beckham Covers Up More Tattoos Linked To His Family Amid Rift -
Shamed Andrew Agreed To ‘go Quietly’ If King Protects Daughters